Single-fraction SBRT with Radixact for lung malignancies: early outcomes of a single-center experience
Francesco Cuccia, Italy | ESTRO | 2026
Early post-SBRT CT patterns and dosimetric factors predict recurrence in solitary lung nodules
María Pagola | ESTRO | 2026
STereotActic Radiotherapy in LOcally advanced non-small cell lung cancer unfit for concurRent chemoraDiation:preliminary results of the STARLORD study
Francesco Cuccia | ESTRO | 2026
Hypofractionated preoperative radiotherapy in soft tissue sarcoma of the extremities andtrunk: outcomes from a prospective phase II study
Anastasia Stergioula | ESTRO | 2026
Stereotactic radiotherapy for non-spine bone metastases: a mono-institutional experience
Francesco Cuccia | ESTRO | 2026
STEREOTACTIC BODY RADIOTHERAPY FOR PERITONEAL OR ABDOMINAL WALL OLIGOMETASTASES: PRELIMINARY RESULTS FROM A MONO-INSTITUTIONAL ANALYSIS
Francesco Cuccia | ESTRO | 2026
Optimizing Liver Dose Constraints in Total Marrow and Lymphoid Irradiation (TMLI) to Reduce the Risk of Veno-Occlusive Disease
Simonetta Saldi | ESTRO | 2026
Initial clinical experience of RayStation-based online adaptive RT using Radixact for endometrial cancer.
Irena Blasiak-Wal, United Kingdom | ESTRO | 2026
One-year cumulative toxicity in 25 prostate cancer patients treated with single fraction (24 Gy) urethra-sparing radiosurgery (PRO-FAST NCT05936736 )
Andrei Fodor, Italy | ESTRO | 2026
Cyberknife UH-SBRT for localized Prostate cancer and DIL: preliminary report of acute and late side effects of the prospective PRO-SPEED trial
Karl Amin, Italy | ESTRO | 2026
EARLY FINDINGS FROM THE STARR (NCT05455736) TRIAL:STEREOTACTIC SALVAGE RADIOTHERAPY FOR MACROSCOPIC RECURRENCE IN THE PROSTATE BED POST-PROSTATECTOMY
Niccolo’ Bertini | ESTRO | 2026
Stereotactic body radiation therapy for intermediate-risk prostate cancer: efficacy and toxicity
María Dolores Espinosa Cuesta | ESTRO | 2026
DVH-based analysis of genitourinary side effects in robotic SBRT prostate treatments
David Sevillano, Spain | ESTRO | 2026
Cyberknife Radiosurgery of Prostate Cancer – Results for 200 Patients
Sebastian Exner, Germany | ESTRO | 2026
Volumetric analysis of Vestibular Schwannoma after Cyberknife Stereotactic Radiosurgery/SBRT: single center study
Maris Mezeckis, Latvia | ESTRO | 2026
Anlotinib Plus Radiotherapy for Newly Diagnosed Pediatric Malignant Brainstem Gliomas: Safety and Efficacy Evaluation
Ying Wang, China | ESTRO | 2026
Cyberknife Stereotactic Radiosurgery For Vestibular Schwannoma: 9-Year Single-Centre Experience
Sandra Lediņa, Latvia | ESTRO | 2026
Association of initial response after stereotactic radiotherapy for symptomatic large brain metastases with neurological improvement and survival
Takayuki Sakurai | ESTRO | 2026
Acoustic Neurinomas Treated with CyberKnife® SRS: Early Experience on Tolerability and Feasibility
Federica Pavoncello, Italy | ESTRO | 2026
Local control after stereotactic radiosurgery and fractionated stereotactic radiotherapy for cerebellopontine angle tumours
Łukasz Raszewsk | ESTRO | 2026
